Medicine composition for preventing and treating schizophrenia

A technology for schizophrenia and composition, which can be used in drug combinations, medical preparations containing active ingredients, and pharmaceutical formulations, etc., and can solve problems such as lack of research literature, difficulty in patients taking medicine, and drug dispersion.

CN105616711AInactive Publication Date: 2016-06-01JINAN XINGYI MEDICAL TECH
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Publication Date
2016-06-01
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

The invention discloses a medicine composition for preventing and treating schizophrenia and a preparation method thereof. The medicine composition is prepared by using eurya japonica, flax leaves, isopimpinellin, adlumidine and pilea pumila as medicinal raw materials in proportions. Various preparations can be prepared from the medicine composition according to conventional preparation processes, and have remarkable curative effects on preventing and treating schizophrenia.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a pharmaceutical composition for preventing and treating schizophrenia and a preparation method thereof. Background technique

[0002] Schizophrenia belongs to the category of epilepsy and madness in Chinese medicine, and its location lies in the mental mechanism. Regulating qi and relieving stagnation, unobstructing the mind, and empathy are the main methods of treatment; the pathogenesis of mad disease is phlegm, fire, blood stasis, obstruction of the heart orifice, imbalance of yin and yang, and loss of control of form and spirit. Adjusting yin and yang and recovering divine mechanism are the fundamental methods. According to modern medicine, schizophrenia is a group of mental diseases with unknown etiology. Its clinical classification is quite detailed, and its treatment has developed rapidly, especially in controlling acute symptoms. Tende...

Examples

Embodiment 1

[0035] Embodiment 1: the pharmaceutical composition for preventing and treating schizophrenia and its preparation method

[0036] The composition and parts by weight of the raw material drug of the pharmaceutical composition for preventing and treating schizophrenia are: 55g of Eustaceae flax leaves, 1420g of iso-anise coumarin, 40g of arginine 110g, 740g of cold water flowers through stems;

[0037] Preparation:

[0038] (1) According to the ratio of raw materials, take Euruma wood, flax leaves, iso-anise coumarin, sagerasin, and stem-penetrating cold water flowers, mix them evenly, use ethanol with a concentration of 42% by weight as a solvent, and extract by warm soaking at 40°C , the number of extractions is 6 times, each extraction time is 0.4 hours, and the amount of solvent used each time is 37.5 times the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A reclaims ethanol, concentrates to relative density 1.20, filte...

Embodiment 2

[0041] Embodiment 2: the pharmaceutical composition for preventing and treating schizophrenia and its preparation method

[0042] The composition and parts by weight of the raw material drug of the pharmaceutical composition for preventing and treating schizophrenia are: 50g of Eustaceae flax leaves, 1430g of isofennel coumarin, 35g of arginine 115g, 720g of cold water flowers through stems;

[0043] Preparation:

[0044] (1) According to the ratio of raw materials, take Euruma wood, flax leaves, iso-anise coumarin, sagerasin, and stem-penetrating cold water flowers, mix them evenly, use ethanol with a concentration of 42% by weight as a solvent, and extract by warm soaking at 40°C , the number of extractions is 6 times, each extraction time is 0.4 hours, and the amount of solvent used each time is 37.5 times the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A reclaims ethanol, concentrates to relative density 1.20, filte...

Embodiment 3

[0047] Embodiment 3: the pharmaceutical composition for preventing and treating schizophrenia and its preparation method

[0048] The composition and parts by weight of the raw material drug of the pharmaceutical composition for preventing and treating schizophrenia are: 60g of Eustaceae flax leaves, 1410g of iso-anise coumarin, 45g of arginine 105g, and 760g of cold water flowers through stems;

[0049] Preparation:

[0050] (1) According to the ratio of raw materials, take Euruma wood, flax leaves, iso-anise coumarin, sagerasin, and stem-penetrating cold water flowers, mix them evenly, use ethanol with a concentration of 42% by weight as a solvent, and extract by warm soaking at 40°C , the number of extractions is 6 times, each extraction time is 0.4 hours, and the amount of solvent used each time is 37.5 times the total weight of the raw material drug, filtered to obtain medicinal residue A and extract A, extract A reclaims ethanol, concentrates to relative density 1.20, f...